This funding opportunity supports early-stage research into medical countermeasures including vaccines, therapeutics, and diagnostics targeting chemical, biological, radiological, and nuclear threats. Applicants must be employed at research organisations eligible for MRC funding. The grant is by invitation only and aims to advance innovative R&D in CBRN threat mitigation.
Applicants must be employed at a research organisation eligible for MRC funding. Employment at an eligible institution is required to apply.
